Concepedia

Publication | Open Access

Muvalaplin, an Oral Small Molecule Inhibitor of Lipoprotein(a) Formation

161

Citations

18

References

2023

Year

Abstract

ClinicalTrials.gov Identifier: NCT04472676.

References

YearCitations

Page 1